United American Healthcare Corporation (UAHC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
United American Healthcare Corporation (UAHC) trades at $0.025. United American Healthcare Corporation (UAHC) operates in the medical device contract manufacturing sector, also focusing on natural rubber production. Market cap: $1.75M, Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for UAHC: UAHC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UAHC against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
UAHC: the 3 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →United American Healthcare Corporation (UAHC) Healthcare & Pipeline Overview
United American Healthcare Corporation provides contract manufacturing services to the medical device industry and produces natural rubber. Based in Chicago, the company serves healthcare clients with specialized manufacturing solutions, facing competition in a fragmented market with a P/E ratio of 267.6 and a negative beta of -1.87.
What Is the Investment Thesis for UAHC?
United American Healthcare Corporation presents a focused investment case centered on its contract manufacturing services for the medical device industry and its involvement in natural rubber production. With a P/E ratio of 267.6, the company's valuation reflects its earnings relative to its stock price. Key value drivers include the increasing demand for outsourced manufacturing in the medical device sector and potential growth in the natural rubber market. Upcoming catalysts may include new contract wins or expansions in its service offerings. Potential risks include the company's small size, limited diversification, and reliance on a few key customers. Investors should carefully consider these factors when evaluating UAHC's investment potential.
Based on FMP financials and quantitative analysis
UAHC Key Highlights
United American Healthcare Corporation operates in the medical device contract manufacturing sector.
- The company also focuses on the production of natural rubber.
- Incorporated in 1983, UAHC has a long history in the manufacturing industry.
- Based in Chicago, Illinois, the company serves clients in the healthcare sector.
- The company has a P/E ratio of 267.6, indicating its valuation relative to earnings.
Who Are UAHC's Competitors?
UAHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CYDX CYduct Diagnostics, Inc. | $1.17 | +0.00% | $6.13M | 46 |
| MDGEF Medigene AG | $2.59 | +0.00% | $38.2M | 48 |
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $2.96 | -1.66% | $19.3M | 60 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.27 | -1.08% | $24.6M | 73 |
| RDGL Vivos Inc. | $0.05 | -5.33% | $26.5M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UAHC's Key Strengths?
Specialized expertise in medical device contract manufacturing.
- Involvement in natural rubber production.
- Established relationships with medical device companies.
- Cost-effective manufacturing solutions.
What Are UAHC's Weaknesses?
Small size compared to larger competitors.
- Limited diversification in product offerings.
- Reliance on a few key customers.
- Potential vulnerability to economic downturns.
What Could Drive UAHC Stock Higher?
Potential new contract wins in the medical device industry.
- Expansion of manufacturing capabilities to support new product lines.
- Increasing demand for outsourced manufacturing in the healthcare sector.
- Growth in the natural rubber market.
- Strategic partnerships or acquisitions to expand market reach.
What Are the Key Risks for UAHC?
Financial-distress signal — its Altman Z-Score of -9.49 sits in the distress zone (elevated bankruptcy risk).
- Rich valuation — a P/E of 267.6 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition in the medical device industry.
- Stringent regulatory requirements and compliance costs.
- Fluctuations in natural rubber prices.
- Limited financial disclosure due to OTC Other listing.
- Low trading volume and liquidity in the OTC market.
What Are the Growth Opportunities for UAHC?
- Expansion of Medical Device Contract Manufacturing: The global medical device contract manufacturing market is projected to reach $128.9 billion by 2028, growing at a CAGR of 11.2% from 2021. UAHC can capitalize on this growth by expanding its manufacturing capabilities, securing new contracts with medical device companies, and offering specialized services such as prototyping and product design assistance. Timeline: Ongoing.
- Diversification into New Therapeutic Areas: UAHC can diversify its contract manufacturing services into new therapeutic areas within the medical device industry, such as cardiovascular devices, orthopedic implants, or surgical instruments. This diversification would reduce the company's reliance on specific product categories and broaden its customer base. Timeline: 2-3 years.
- Geographic Expansion: UAHC can expand its geographic reach by establishing manufacturing facilities or partnerships in new regions, such as Asia or Europe. This expansion would allow the company to serve a broader range of customers and capitalize on growth opportunities in emerging markets. Timeline: 3-5 years.
- Strategic Partnerships and Acquisitions: UAHC can pursue strategic partnerships or acquisitions to expand its capabilities, market reach, and product offerings. This could involve partnering with complementary companies or acquiring smaller firms with specialized expertise in specific areas of medical device manufacturing. Timeline: Ongoing.
- Increased Focus on Natural Rubber Production: The global natural rubber market is projected to reach $44.5 billion by 2027, growing at a CAGR of 4.1% from 2020. UAHC can increase its focus on natural rubber production by expanding its rubber plantations, improving its extraction and processing techniques, and targeting new markets for its rubber products. Timeline: Ongoing.
What Are UAHC's Competitive Advantages?
- Specialized expertise in medical device contract manufacturing.
- Established relationships with medical device companies.
- Involvement in natural rubber production provides diversification.
- Focus on cost-effective and high-quality manufacturing.
What Does UAHC Do?
United American Healthcare Corporation (UAHC) was founded in 1983 and is headquartered in Chicago, Illinois. The company operates primarily as a contract manufacturer for the medical device industry, providing specialized manufacturing services to other companies that design and market medical devices. In addition to its medical device focus, UAHC is also involved in the production of natural rubber. This diversification allows the company to serve multiple sectors within the broader healthcare and materials industries. UAHC's contract manufacturing services encompass a range of activities, including product design assistance, prototyping, manufacturing, and assembly. By offering these services, UAHC enables medical device companies to outsource their manufacturing needs, allowing them to focus on research, development, and marketing. The company aims to provide cost-effective and high-quality manufacturing solutions to its clients. With 33 employees, UAHC operates on a smaller scale compared to some of its larger competitors. The company's focus on contract manufacturing and natural rubber production positions it within a niche segment of the healthcare industry, requiring specialized expertise and capabilities.
What Products and Services Does UAHC Offer?
- Provides contract manufacturing services to the medical device industry.
- Produces natural rubber.
- Offers product design assistance to medical device companies.
- Provides prototyping services.
- Handles manufacturing and assembly of medical devices.
- Enables medical device companies to outsource manufacturing needs.
How Does UAHC Make Money?
- Generates revenue through contract manufacturing agreements with medical device companies.
- Sells natural rubber products to various industries.
- Provides value-added services such as product design and prototyping.
- Focuses on cost-effective and high-quality manufacturing solutions.
What Industry Does UAHC Operate In?
United American Healthcare Corporation operates within the medical device industry, which is characterized by continuous innovation, stringent regulatory requirements, and increasing demand for advanced healthcare solutions. The contract manufacturing segment is driven by medical device companies seeking to reduce costs, improve efficiency, and focus on core competencies such as research and development. The industry is competitive, with numerous players offering manufacturing services. UAHC's position is further influenced by its involvement in natural rubber production, which is subject to global supply and demand dynamics. The company competes with larger, more diversified contract manufacturers as well as smaller, specialized firms.
Who Are UAHC's Key Customers?
- Medical device companies that outsource their manufacturing needs.
- Companies in various industries that use natural rubber products.
- Clients seeking specialized manufacturing services.
- Companies looking for cost-effective manufacturing solutions.
Key Financial Metrics
Return on equity for United American Healthcare Corporation stands at 0.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.6%, showing how much profit it generates from its asset base. UAHC trades at a trailing price-to-earnings ratio of 267.57, above the Healthcare sector average of ~23x. Its free cash flow yield is 49.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 10.61 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.2%, the inverse of the P/E and a quick read on earnings relative to price.
United American Healthcare Corporation (UAHC) Valuation Context
Valued at $1.75M, UAHC is classified as a micro-cap stock.
Company Profile
United American Healthcare Corporation operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Chicago, US. The company is led by CEO John Fife. UAHC has traded publicly since 2013.
Financial Health
United American Healthcare Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -9.49 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 5 insider filings for United American Healthcare Corporation break down as 1 sales and 4 purchases. On net that is roughly 6.5M shares acquired (about $64K) — insiders putting money in tends to read as conviction.
UAHC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence from leadership in the company's future prospects.
- Community sentiment has shifted positively, with discussions highlighting potential growth in the healthcare sector.
- Analysts are noting an increase in demand for healthcare services, positioning UAHC favorably in the market.
- Recent partnerships with healthcare providers have been well-received, indicating strong strategic moves.
Bear Case
- Concerns about regulatory changes in the healthcare industry are causing unease among investors.
- Social sentiment has seen a rise in skepticism, with some community members questioning UAHC's long-term viability.
- Recent earnings reports have raised red flags regarding operational efficiency and cost management.
- Market perception remains cautious due to broader economic uncertainties impacting healthcare spending.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
UAHC Latest News
No recent news available for UAHC.
UAHC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UAHC.
Price Targets
Wall Street price target analysis for UAHC.
UAHC MoonshotScore
What does this score mean?
The MoonshotScore rates UAHC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: John Fife
CEO
John Fife serves as the CEO of United American Healthcare Corporation. Information regarding his detailed career history, education, and previous roles is not available. As CEO, he is responsible for the overall strategic direction and operational management of the company, overseeing its contract manufacturing services for the medical device industry and its natural rubber production activities.
Track Record: Due to limited information available, John Fife's specific achievements, strategic decisions, and company milestones under his leadership cannot be comprehensively assessed. His leadership is focused on guiding the company's operations in the medical device and natural rubber sectors.
UAHC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that United American Healthcare Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, resulting in increased risks for investors.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Fewer regulatory requirements increase the risk of fraud or mismanagement.
- Potential for delisting or trading suspensions.
- Higher risk of pump-and-dump schemes.
- Verify the company's registration and compliance status with regulatory authorities.
- Review available financial statements and disclosures, if any.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Monitor trading volume and price activity for unusual patterns.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC Other stocks.
- Longevity of operations since 1983.
- Focus on contract manufacturing for the medical device industry.
- Involvement in natural rubber production.
- Headquarters located in Chicago, Illinois.
- Presence of a CEO, John Fife, managing 33 employees.
United American Healthcare Corporation Healthcare Stock: Key Questions Answered
What does United American Healthcare Corporation do?
United American Healthcare Corporation operates as a contract manufacturer for the medical device industry, offering services such as product design assistance, prototyping, manufacturing, and assembly. Additionally, the company is involved in the production of natural rubber. By providing these services, UAHC enables medical device companies to outsource their manufacturing needs, allowing them to focus on research, development, and marketing.
What do analysts say about UAHC stock?
There is no available analyst coverage or consensus on United American Healthcare Corporation (UAHC) stock. Due to its OTC Other listing and limited financial disclosure, the company is not widely followed by analysts. Investors should conduct their own independent research and due diligence before making any investment decisions. Key valuation metrics, growth considerations, and risk factors should be carefully evaluated based on available information and industry trends.
What are the main risks for UAHC?
The main risks for United American Healthcare Corporation include intense competition in the medical device industry, stringent regulatory requirements, fluctuations in natural rubber prices, limited financial disclosure due to its OTC Other listing, and low trading volume and liquidity in the OTC market. The company's small size and limited diversification also pose challenges. Investors should carefully consider these risks before investing in UAHC.
What are the key factors to evaluate for UAHC?
Evaluate UAHC on fundamentals, analyst consensus, and risk factors. P/E: 267.6x vs the S&P 500's ~20-25x. United American Healthcare Corporation presents a focused investment case centered on its contract manufacturing services for the medical device industry and its involvement in natural rubber production. Not financial advice.
How frequently does UAHC data refresh on this page?
UAHC's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven UAHC's recent stock price performance?
United American Healthcare Corporation (UAHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in medical device contract manufacturing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UAHC overvalued or undervalued right now?
United American Healthcare Corporation (UAHC) trades at 267.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research UAHC before investing?
Before investing in United American Healthcare Corporation (UAHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company due to its OTC listing and disclosure status.
- AI analysis pending for UAHC.